semaglutide memory loss Drug maker Novo Nordisk has announced that its weight-loss drug failed to slow down the decline in and thinking in people with early Alzheimer's disease. This disappointing news will come Semaglutide GLP-1 for Weight Loss

Young-Hyman D, de Groot M, Hill-Briggs F, Gonzalez JS, Hood K, Peyrot M

Pernicious anemia is an autoimmune disease in which the immune system attacks the parietal cells of the stomach which produce intrinsic factor, a protein normally responsible for most of the bodys B12 absorption

The STEP 5 clinical trial (using the Wegovy formulation of semaglutide) confirmed safety and effectiveness for up to 2 years, with participants maintaining 15.2% body weight reduction compared to just 2.6% with placebo

Side effect profiles are similar between routes and include nausea, reduced appetite, and mild gastrointestinal changes during initial weeksthese typically resolve as your body adapts